These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15857144)

  • 21. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist.
    Gunnet JW; Wines P; Xiang M; Rybczynski P; Andrade-Gordon P; de Garavilla L; Parry TJ; Cheung WM; Minor L; Demarest KT; Maryanoff BE; Damiano BP
    Eur J Pharmacol; 2008 Aug; 590(1-3):333-42. PubMed ID: 18599033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
    J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.
    Tsukamoto I; Koshio H; Kuramochi T; Saitoh C; Yanai-Inamura H; Kitada-Nozawa C; Yamamoto E; Yatsu T; Shimada Y; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2009 Apr; 17(8):3130-41. PubMed ID: 19321349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of photoaffinity labeled fusidic acid analogues.
    Riber D; Venkataramana M; Sanyal S; Duvold T
    J Med Chem; 2006 Mar; 49(5):1503-5. PubMed ID: 16509567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (D-(p-benzoylphenylalanine)13, tyrosine19)-melanin-concentrating hormone, a potent analogue for MCH receptor crosslinking.
    Drozdz R; Hintermann E; Tanner H; Zumsteg U; Eberle AN
    J Pept Sci; 1999 May; 5(5):234-42. PubMed ID: 10363906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
    Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI
    FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor.
    Breton C; Chellil H; Kabbaj-Benmansour M; Carnazzi E; Seyer R; Phalipou S; Morin D; Durroux T; Zingg H; Barberis C; Mouillac B
    J Biol Chem; 2001 Jul; 276(29):26931-41. PubMed ID: 11337500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations.
    Guillon G; Derick S; Pena A; Cheng LL; Stoev S; Seyer R; Morgat JL; Barberis C; Gal CS; Wagnon J; Manning M
    J Neuroendocrinol; 2004 Apr; 16(4):356-61. PubMed ID: 15089974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New, potent, selective, and short-acting peptidic V1a receptor agonists.
    Wisniewski K; Galyean R; Tariga H; Alagarsamy S; Croston G; Heitzmann J; Kohan A; Wisniewska H; Laporte R; Rivière PJ; Schteingart CD
    J Med Chem; 2011 Jul; 54(13):4388-98. PubMed ID: 21688787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding.
    Priego EM; Pérez-Pérez MJ; von Frijtag Drabbe Kuenzel JK; de Vries H; Ijzerman AP; Camarasa MJ; Martín-Santamaría S
    ChemMedChem; 2008 Jan; 3(1):111-9. PubMed ID: 18000937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonist.
    Carnazzi E; Aumelas A; Phalipou S; Mouillac B; Guillon G; Barberis C; Seyer R
    Eur J Biochem; 1997 Aug; 247(3):906-13. PubMed ID: 9288914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships.
    D'Addona D; Carotenuto A; Novellino E; Piccand V; Reubi JC; Di Cianni A; Gori F; Papini AM; Ginanneschi M
    J Med Chem; 2008 Feb; 51(3):512-20. PubMed ID: 18210999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a new class of macrocyclic antagonists to the human motilin receptor.
    Marsault E; Hoveyda HR; Peterson ML; Saint-Louis C; Landry A; Vézina M; Ouellet L; Wang Z; Ramaseshan M; Beaubien S; Benakli K; Beauchemin S; Déziel R; Peeters T; Fraser GL
    J Med Chem; 2006 Nov; 49(24):7190-7. PubMed ID: 17125271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
    Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
    J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes.
    Nikulin VI; Rakov IM; De Los Angeles JE; Mehta RC; Boyd LY; Feller DR; Miller DD
    Bioorg Med Chem; 2006 Mar; 14(6):1684-97. PubMed ID: 16431119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.